This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Scott Royal
President & Chief Executive Officer
Contact
ScottRoyal@westat.comOverview
Scott Royal, PhD, serves as the President and Chief Executive Officer of Westat. He joined Westat in November 2017 as President, was elected to the Board of Directors in May 2018, and became CEO in 2020.
Royal has a strong background in public health research, with a focus on HIV prevention and its impact on disadvantaged communities. Throughout his career, he has conducted a range of research on HIV, led large epidemiologic projects, and built up public health and epidemiologic practice capacities. Over the years, he has transitioned from frontline research to corporate leadership, where he excels in bringing talented people together and enhancing how they perform on all dimensions of research work.
Royal has also served the community at large on the Board of Directors for Metro Teen AIDS in Washington, DC, and Capital Caring (Hospice) in Falls Church, Virginia. He currently serves on the Board of Directors for the Children’s Inn at the National Institutes of Health and the Beebe Medical Foundation Board in Lewes, Delaware.
Education
- PhD, Bloomberg School of Public Health at Johns Hopkins University
- MPH, Bloomberg School of Public Health at Johns Hopkins University
- BA, Furman University
-
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine
Contemporary Clinical Trials
January 2023
N.A. Scott, C. Sadowski, A. Vernon, B. Arevalo, K. Beer, A. Borisov, J.A. Cayla, et al.
DOILink for: Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine -
Theory, methods, and operational results of the Young Women's Health History Study: A study of young-onset breast cancer incidence in Black and White women
32,
Cancer Causes and Control
January 2021
E.M. Velie, L.R. Marcus, D.R. Pathak, A.S. Hamilton, R. DiGaetano, R. Klinger, B. Gollapudi, et al.
DOILink for: Theory, methods, and operational results of the Young Women's Health History Study: A study of young-onset breast cancer incidence in Black and White women -
Improved veteran access to care through the Veteran Health Information Exchange (VHIE) Retail Immunization Coordination Project
January 2016
N. Botts, E. Pan, L. Olinger, M. Donahue, N. Hsing
SOURCEImproved veteran access to care through the Veteran Health Information Exchange (VHIE) Retail Immunization Coordination Project